Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells Within the Tumor Microenvironment
Open Access
- 4 August 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1895
Abstract
This review delves into the characteristics of lipid metabolism reprogramming in cancer cells and immune cells within the tumor microenvironment (TME), discussing its role in tumorigenesis and development and analyzing the value of lipid metabolism-related molecules in tumor diagnosis and prognosis. Cancer cells support their rapid growth through aerobic glycolysis and lipid metabolism reprogramming. Lipid metabolism plays distinct roles in cancer and immune cells, including energy supply, cell proliferation, angiogenesis, immune suppression, and tumor metastasis. This review focused on shared lipid metabolic enzymes and transporters, lipid metabolism-related oncogenes and non-coding RNAs (ncRNAs) involved in cancer cells, and the influence of lipid metabolism on T cells, dendritic cells (DCs), B cells, tumor associated macrophages (TAMs), tumor associated neutrophils (TANs), and natural killer cells (NKs) within TME. Additionally, the role of lipid metabolism in tumor diagnosis and prognosis was explored, and lipid metabolism-based anti-tumor treatment strategies were summarized, aiming to provide new perspectives for achieving precision medicine.Keywords
This publication has 258 references indexed in Scilit:
- Platelet‐activating factor: a potential therapeutic target to improve cancer immunotherapyMolecular Oncology, 2024
- Region‐Specific CD16+ Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer CellsAdvanced Science, 2024
- Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor ProgressionAdvanced Science, 2024
- Plasma lipid levels are associated with the CD8+ T‐cell infiltration and prognosis of patients with pancreatic cancerCancer Medicine, 2023
- Lipid metabolism–related lncRNA SLC25A21‐AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c‐Myc axis and SLC25A21 expressionClinical and Translational Medicine, 2022
- Therapeutic efficacy of FASN inhibition in preclinical models of HCCHepatology, 2022
- Therapeutic targeting of hepatic ACSL4 ameliorates NASH in miceHepatology, 2021
- A Novel Long Non‐Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol SynthesisAdvanced Science, 2020
- LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancerCancer Communications, 2020
- Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescentsCochrane Database of Systematic Reviews, 2017